Related Topics
Applying the lessons of COVID-19
Factors that contributed to the rapid pace of COVID-19 vaccine development could be applied to future epidemics and other global health challenges, according to an article co-authored by Harvard T.H. Chan School of Public Health’s David Bloom.
Ensuring safe and effective COVID-19 vaccines for vulnerable populations
Although COVID-19 vaccines have begun reaching people around the world, challenges remain to ensuring that the vaccines help those who are most vulnerable, according to an article co-authored by experts from Harvard T.H. Chan School of Public Health.
Already vaccinated? Keep masking up anyway.
Atul Gawande was quoted on COVID-19 vaccines, wearing masks, and other pandemic-related topics in several media outlets.
The Big 3: Ensuring equity in COVID-19 vaccine distribution
Research scientist Rebekka Lee discusses how best to ensure that COVID-19 vaccines are distributed equitably in Massachusetts.
After a long pandemic year, experts look to the future
Harvard Chan School experts offer advice on how the new Biden administration can best tackle the pandemic.
Assessing the effectiveness of public health ads
Public health advertising that incites fear is often less effective than messaging that provides clear steps about staying healthy and saving lives, according to experts.
Overcoming the initial challenges of the COVID-19 vaccine rollout
Howard Koh, Harvey V. Fineberg Professor of the Practice of Public Health Leadership, discusses the initial challenges of COVID-19 vaccination efforts in the U.S. and the need for a “one government” approach.
Opinion: Roll out vaccines using honor code
Distributing COVID-19 vaccines according to an honor code could minimize bureaucratic red tape and help hasten the rollout, according to experts from Ariadne Labs and Harvard T.H. Chan School of Public Health.
‘An enormous victory for public health’
Jaap Goudsmit, adjunct professor of epidemiology and infectious diseases and chief scientific officer of the Human Immunomics Initiative, a joint project between Harvard Chan School and the Human Vaccines Project, discusses COVID vaccines.
Commentary: Building trust in COVID-19 vaccines
Researchers, industry leaders, and policymakers should work to build trust in COVID-19 vaccines among communities of color—and, beyond that, should seek to include these communities as equal partners in the research enterprise, according to new commentary.